Edition:
United States

Transgenomic Inc (TBIO.PK)

TBIO.PK on OTC Markets Group

0.57USD
24 Mar 2017
Change (% chg)

$0.00 (+0.53%)
Prev Close
$0.57
Open
$0.57
Day's High
$0.59
Day's Low
$0.57
Volume
105,956
Avg. Vol
2,551,982
52-wk High
$1.59
52-wk Low
$0.15

TBIO.PK

Chart for TBIO.PK

About

Transgenomic, Inc. is a biotechnology company. The Company is engaged in advancing personalized medicine for the detection and treatment of cancer, and inherited diseases through its molecular technologies and clinical and research services. The Company operates through its Laboratory Services segment. The Company is engaged in... (more)
No analyst recommendations are available for TBIO.PK.

Overall

Beta: 0.11
Market Cap(Mil.): $14.13
Shares Outstanding(Mil.): 24.79
Dividend: --
Yield (%): --

Financials

  TBIO.PK Industry Sector
P/E (TTM): -- 47.98 29.94
EPS (TTM): -0.50 -- --
ROI: -- -2.56 13.01
ROE: -- 5.14 14.16

More From Around the Web

Competitors

  Price Chg
Roche Holding Ltd. (ROG.S) CHF252.90 +0.30
Roche Holding Ltd. (RO.S) CHF252.50 0.00
Sanofi SA (SASY.PA) €82.87 -0.43
Qiagen NV (QGEN.OQ) $28.93 +0.19
Sequenom, Inc. (SQNM.OQ) -- --
Merck KGaA (MRCG.DE) €103.85 +1.70

Earnings vs. Estimates